| Report description | | | | market data tables, 40 competitive company profiles, |
| Technological innovations in the medical device | | | | analysis of 300 patents and minimum 50 micro |
| industry have led to a radical transformation in patient | | | | markets, which are collectively exhaustive and |
| care. This report identifies the sectors with the | | | | mutually exclusive. |
| industry’s most important developments related | | | | • No single report by any other publisher provides |
| to patient care, clinical outcomes, and new product | | | | market data for all the segments viz products, |
| development. While the scope of the report is limited | | | | services, applications, ingredients, technology, and |
| to the top ten technologies only, it covers almost the | | | | stakeholders in a single report for all the four |
| entire medical device market. | | | | geographies - US, Europe, APAC, ROW. |
| Scientific and medical technology breakthroughs – | | | | • We provide 10% customization - Research |
| such as minimally invasive surgery (MIS) – have | | | | shows that more than 40% of the times, clients do |
| accelerated the accuracy of clinical outcomes and | | | | not get the specific intelligence they need in |
| have also reduced recovery times and the medical | | | | multi-client market research reports. We offer 10% |
| costs borne by patients. This has led to radical | | | | customization in our reports at no extra cost. Get |
| transformation in patient care. | | | | the exact market intelligence you require with real |
| IT integration in medical imaging and medical devices | | | | value for money. |
| has given a significant boost to the healthcare | | | | • 15 pages of high level analysis including |
| industry, a trend that is apparent in the market | | | | benchmarking strategies, best practices and the |
| growth of drug eluting stents and telemedicine | | | | market’s cash cows (BCG matrix). We conduct |
| technologies. The markets covered in the report | | | | detailed market positioning, product positioning and |
| have a current potential of $454.3 billion and are | | | | competitive positioning. Entry strategies, gaps and |
| expected to grow at a CAGR of 9.8% between | | | | opportunities are identified for all the stakeholders. |
| 2009 and 2014. | | | | • Comprehensive market analysis for |
| Market estimates and forecast | | | | pharmaceutical and biotech companies, medical device |
| The report provides in-depth market estimates and | | | | manufacturers, pharma-research labs, doctors, |
| forecast for top ten medical device technologies as | | | | physicians and hospitals, medical/pharma associations, |
| follows: | | | | retailers and super-retailers, technology providers, and |
| • Diagnostic imaging (nuclear imaging, interventional | | | | research and development (R&D) companies. |
| radiology, capsule endoscopy and others) | | | | Key questions answered |
| • Drug delivery (needle free injections, transdermal | | | | • Which are the high-growth segments/cash cows |
| systems, inhalation system, infusion system) | | | | and how is the market segmented in terms of |
| • Molecular diagnostics (biosensors, proteomics, | | | | applications, products, services, ingredients, |
| nanotechnology, and others) | | | | technologies, and stakeholders? |
| • Mobility aid technologies | | | | • What are market estimates and forecasts; |
| • Minimal/non-invasive surgery (stents, bariatric | | | | which markets are doing well and which are not? |
| surgery, medical robotics and others) | | | | • Where are the gaps and opportunities; what is |
| • Micro-fluids and MEMS (Miniature medical | | | | driving the market? |
| pressure sensors, bio chips, protein chips) | | | | • Which are the key playing fields? Which are the |
| • Non-invasive monitoring (continuous blood | | | | winning edge imperatives? |
| glucose monitoring) | | | | • How is the competitive outlook; who are the |
| • Biomaterials (bionic limbs, joint replacement, | | | | main players in each of the segments; what are the |
| antimicrobial wound dressing and others) | | | | key selling products; what are their strategic |
| • Bio-implants (neurostimulation and others) | | | | directives, operational strengths and product |
| • Tele-medicines | | | | pipelines? Who is doing what? |
| Each section will provide market data, market drivers, | | | | Powerful Research and Analysis |
| trends and opportunities, top-selling products, key | | | | The analysts working come from renowned |
| players, and competitive outlook. This report will also | | | | publishers and market research firms, globally, adding |
| provide more than 100 market tables for various | | | | their expertise and domain understanding. We get the |
| geographic regions covering the sub-segments and | | | | facts from over 22,000 news and information |
| micro-markets. In addition, the report also provides | | | | sources, a huge database of key industry participants |
| 50 company profiles for each of its sub-segments. | | | | and draw on our relationships with more than 900 |
| What makes our reports unique? | | | | market research companies across the world. We are |
| • We provide the longest market segmentation | | | | inspired to help our clients grow by providing |
| chain in this industry- not many reports provide | | | | qualitative business insights with our huge market |
| market breakdown upto level 5. | | | | intelligence repository. |
| • Each report is about 250 pages with 100+ | | | | |